From Concept to Candidates: Functional Lead Discovery for Next-Gen Therapeutics Functional screening can make or break the success of an antibody discovery campaign. In this webinar, ProBio experts share an integrated discovery strategy that enables earlier functional screening, improves hit rates, and accelerates the path from concept to candidate. Learn how Powerdoma™ streamlines antibody discovery by enabling functional validation without subcloning. Key topics include the role of functional screening in antibody discovery, comparisons of Hybridoma, Single B Cell, and Phage Display platforms, and case studies demonstrating faster turnaround, reduced costs, and improved candidate selection. Dr. Derek ChenSenior Director, Antibody Drug Discovery Watch now Related service: Therapeutic Antibody Discovery Services Hybridoma Generation for Therapeutic Antibody Discovery ProSpeed™ Single B cell Antibody Discovery Human Fab Naïve Library « Previous Page ProBio Announces New Executive Appointments Next Page ProBio Accelerates Chimagen's Global Market Expansion, Paving the Way for Innovative Antibody Therapy » Contact us Phone: 1-877-436-7274 (Toll-Free); 1-732-885-9188 Fax: 1-732-210-0262
Latest WebinarsFrom Concept to Candidates: Functional Lead Discovery for Next-Gen TherapeuticsHybrid Seminar – CMC and Regulatory Strategies for Antibody Therapeutics (mAbs, BsAbs & TsAbs)Webinar – Reduce Risk in VHH and BsAb Discovery with Early Immunogenicity AssessmentAccelerating In Vivo CAR-T Antibody Discovery and DevelopmentFind More Therapeutic Antibody Categories